H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study

World Journal of Biological Psychiatry

Volumn 15, Issue 4, 2014, Pages 298-306

  Harel, Eiran Vadim ^a   Rabany, Liron ^a,b   Deutsch, Lisa ^c   Bloch, Yuval ^a,b   Zangen, Abraham ^d   Levkovitz, Yechiel ^a,b  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Gordon Faculty of Social Sciences Tel Aviv University ^*  (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Continuation treatment; Major depressive disorder; Medication resistance; Neuromodulation; Transcranial magnetic stimulation (TMS)

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEEP TMS H COIL; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROLOGICAL THERAPEUTIC DEVICE; PROBABILITY; REMISSION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84900835214     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.639802     Document Type: Article

References (29)

1. Abraham G, O'Brien S. 2002. Repetitive transcranial magnetic stimulation is useful for maintenance treatment. Can J Psychiatry 47:386.
2. Benadhira R, Saba G, Samaan A, Dumortier G, Lipski H, Gastal D, et al. 2005. Transcranial magnetic stimulation for refractory depression. Am J Psychiatry 162:193.
3. Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ. 2010. Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia. Curr Opin Psychiatry 23:85-90.
4. Burt T, Lisanby SH, Sackeim HA. 2002. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 5:73-103.
5. Couturier JL. 2005. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-Analysis. J Psychiatry Neurosci 30:83-90.
6. Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papa-dopoulos A, Cleare AJ. 2009. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116:4-11.
7. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Cas-tella A, Kulkarni J. 2003. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 60:1002-1008.
8. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. 1991. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851-855.
9. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 67:507-516.
10. Greden JF. 2001. The burden of disease for treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):26-31.
11. Herwig U, Fallgatter AJ, Hoppner J, Eschweiler GW, Kron M, Hajak G, et al. 2007. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry 191:441-448.
12. Holtzheimer PE III, Russo J, Avery DH. 2001. A meta-Analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull 35:149-169.
13. Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, et al. 2011. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 128:235-242.
14. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63:1337-1344
15. Kozel FA, George MS. 2002. Meta-Analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract 8:270-275.
16. Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. 2007. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol 118:2730-2744.
17. Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, et al. 2009. Deep transcranial magnetic stimulation over the prefron-tal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2:188-200.
18. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
19. Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kuli-sevsky J, et al. 2002. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev CD003493.
20. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. 2005. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 66:1524-1528.
21. O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62:1208-1216.
22. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. 2009. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. J Clin Neurophysiol 120:2008-2039.
23. Roth Y, Zangen A, Hallett M. 2002. A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophys-iol 19:361-370.
24. Roth Y, Amir A, Levkovitz Y, Zangen A. 2007. Three-dimensional distribution of the electric field induced in the brain by tran-scranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 24:31-38.
25. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR * D report. Am J Psychiatry 163:1905-1917.
26. Schutter DJ. 2009. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral pre-frontal cortex in double-blind sham-controlled designs: a meta-Analysis. Psychol Med 39:65-75.
27. Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
28. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. 2004. Global burden of depressive disorders in the year 2000. Br J Psychiatry 184:386-392.
29. Zangen A, Roth Y, Voller B, Hallett M. 2005. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 116:775-779.